Hemostasis
Hemostasis is a medical device company that develops and manufactures hemostatic agents and related products used by healthcare providers to control bleeding during surgical and interventional procedures. It sells its products primarily to hospitals and surgical centers through direct and distributor channels.
- Revenue
- $8.0M
- Employees
- 35
- Founded
- 1998
- Headquarters
- Saint Paul, United States of America
What 5 Arbolus experts think of Hemostasis
NPS scores are generally positive, with 67% of responses in the 7-10 range and no scores below 6. Customers with longer-term adoption and daily use report the highest satisfaction. Renewal intent, where specified, is uncertain among influencers, but long tenure across users implies stable stickiness. Most implementations are classified as more than 1 year old (83%), reflecting established product adoption with minimal recent offboarding.Overall Customer Sentiment: Positive
Who reviewed Hemostasis
- C-Suite 80% (4)
- Manager 20% (1)
Employer names and spend open once the report publishes.
Tell us when the Hemostasis report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
40 Net Promoter Score, from 5 scored reviews- Promoters 2
- Passives 3
- Detractors 0
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 0%Plan to renew, by seniority
- 0% 1 answer
- 7/10 Average score from undecided customers
For people who use Hemostasis
Do you use Hemostasis at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 5 customers of Hemostasis have already contributed
Takes a few minutes. Your identity stays anonymous.